Physician profile
John H Milek
NPI 1528179512
$1,270.41
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $15.47 · 2021: $68.23 · 2022: $192 · 2023: $156 · 2024: $24.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $530.00 | 2019 | |
| Abbvie INC. | $373.38 | 2019-2023 | |
| Pfizer INC. | $101.35 | 2019-2023 | |
| Hologic Sales and Service, LLC | $56.27 | 2019-2023 | Aptima |
| Astellas Pharma US INC | $51.07 | 2019-2024 | Veozah |
| Aspira Women'S Health INC | $48.88 | 2021-2024 | Ova1 |
| Davol INC. | $29.18 | 2023 | Arista Ah Flexitip |
| Avion Pharmaceuticals | $27.27 | 2019 | |
| Millicent US INC | $16.44 | 2023 | Femring, Intrarosa |
| Takeda Pharmaceuticals U.S.A., INC. | $13.51 | 2019 | |
| Virtus Pharmaceuticals LLC | $11.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Milek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.